Literature DB >> 23366526

Segmenting human motion for automated rehabilitation exercise analysis.

Jonathan Feng-Shun Lin1, Dana Kulić.   

Abstract

This paper proposes an approach for the automated segmentation and identification of movement segments from continuous time series data of human movement, collected through motion capture of ambulatory sensors. The proposed approach uses a two stage identification and recognition process, based on velocity and stochastic modeling of each motion to be identified. In the first stage, motion segment candidates are identified based on a unique sequence of velocity features such as velocity peaks and zero velocity crossings. In the second stage, Hidden Markov models are used to accurately identify segment locations from the identified candidates. The approach is capable of on-line segmentation and identification, enabling interactive feedback in rehabilitation applications. The approach is validated on a rehabilitation movement dataset, and achieves a segmentation accuracy of 89%.

Entities:  

Mesh:

Year:  2012        PMID: 23366526     DOI: 10.1109/EMBC.2012.6346565

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  3 in total

1.  Segmenting Continuous Motions with Hidden Semi-markov Models and Gaussian Processes.

Authors:  Tomoaki Nakamura; Takayuki Nagai; Daichi Mochihashi; Ichiro Kobayashi; Hideki Asoh; Masahide Kaneko
Journal:  Front Neurorobot       Date:  2017-12-21       Impact factor: 2.650

2.  HVGH: Unsupervised Segmentation for High-Dimensional Time Series Using Deep Neural Compression and Statistical Generative Model.

Authors:  Masatoshi Nagano; Tomoaki Nakamura; Takayuki Nagai; Daichi Mochihashi; Ichiro Kobayashi; Wataru Takano
Journal:  Front Robot AI       Date:  2019-11-20

3.  Tracking and Classification of Head Movement for Augmentative and Alternative Communication Systems.

Authors:  Carlos Wellington P Gonçalves; Rogério A Richa; Antonio P L Bo
Journal:  Sensors (Basel)       Date:  2022-01-07       Impact factor: 3.576

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.